Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9579033rdf:typepubmed:Citationlld:pubmed
pubmed-article:9579033lifeskim:mentionsumls-concept:C0021242lld:lifeskim
pubmed-article:9579033lifeskim:mentionsumls-concept:C0184661lld:lifeskim
pubmed-article:9579033lifeskim:mentionsumls-concept:C0005036lld:lifeskim
pubmed-article:9579033lifeskim:mentionsumls-concept:C0220781lld:lifeskim
pubmed-article:9579033lifeskim:mentionsumls-concept:C1883254lld:lifeskim
pubmed-article:9579033lifeskim:mentionsumls-concept:C1521827lld:lifeskim
pubmed-article:9579033lifeskim:mentionsumls-concept:C0449719lld:lifeskim
pubmed-article:9579033lifeskim:mentionsumls-concept:C0679622lld:lifeskim
pubmed-article:9579033lifeskim:mentionsumls-concept:C0205314lld:lifeskim
pubmed-article:9579033lifeskim:mentionsumls-concept:C0332514lld:lifeskim
pubmed-article:9579033lifeskim:mentionsumls-concept:C0082351lld:lifeskim
pubmed-article:9579033lifeskim:mentionsumls-concept:C0596741lld:lifeskim
pubmed-article:9579033pubmed:issue4lld:pubmed
pubmed-article:9579033pubmed:dateCreated1998-6-4lld:pubmed
pubmed-article:9579033pubmed:abstractTextAn asymmetric total synthesis of natural (+)-duocarmycin SA (1) starting from L-malic acid (7) was achieved as shown in Chart 5, establishing firmly the absolute configuration of 1. In order to find suitable reaction conditions for the key step, i.e., the formation of an alkoxyindole derivative, model compounds 9 and 40 were synthesized and two acetalization conditions using i) 2-ethyl-2-methyl-1,3-dioxane and boron trifluoride etherate, and ii) 1,3-bis(trimethylsilyloxy)propane and trimethylsilyl triflate were found to be effective. The former conditions were successfully applied to total synthesis and 49b was prepared from 48 in 54% yield. Further elaborations including i) Curtius rearrangement of 53b to 56, and ii) cleavage of the primary benzyloxy group in the presence of the secondary one in its close vicinity (56-->57) led to the relay compound 62, whose conversion to 1 has already been accomplished.lld:pubmed
pubmed-article:9579033pubmed:languageenglld:pubmed
pubmed-article:9579033pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9579033pubmed:citationSubsetIMlld:pubmed
pubmed-article:9579033pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9579033pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9579033pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9579033pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9579033pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9579033pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9579033pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9579033pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9579033pubmed:statusMEDLINElld:pubmed
pubmed-article:9579033pubmed:monthAprlld:pubmed
pubmed-article:9579033pubmed:issn0009-2363lld:pubmed
pubmed-article:9579033pubmed:authorpubmed-author:MatsumuraNNlld:pubmed
pubmed-article:9579033pubmed:authorpubmed-author:NatsumeMMlld:pubmed
pubmed-article:9579033pubmed:authorpubmed-author:MuratakeHHlld:pubmed
pubmed-article:9579033pubmed:issnTypePrintlld:pubmed
pubmed-article:9579033pubmed:volume46lld:pubmed
pubmed-article:9579033pubmed:ownerNLMlld:pubmed
pubmed-article:9579033pubmed:authorsCompleteYlld:pubmed
pubmed-article:9579033pubmed:pagination559-71lld:pubmed
pubmed-article:9579033pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:9579033pubmed:meshHeadingpubmed-meshheading:9579033-...lld:pubmed
pubmed-article:9579033pubmed:meshHeadingpubmed-meshheading:9579033-...lld:pubmed
pubmed-article:9579033pubmed:meshHeadingpubmed-meshheading:9579033-...lld:pubmed
pubmed-article:9579033pubmed:meshHeadingpubmed-meshheading:9579033-...lld:pubmed
pubmed-article:9579033pubmed:meshHeadingpubmed-meshheading:9579033-...lld:pubmed
pubmed-article:9579033pubmed:meshHeadingpubmed-meshheading:9579033-...lld:pubmed
pubmed-article:9579033pubmed:meshHeadingpubmed-meshheading:9579033-...lld:pubmed
pubmed-article:9579033pubmed:meshHeadingpubmed-meshheading:9579033-...lld:pubmed
pubmed-article:9579033pubmed:meshHeadingpubmed-meshheading:9579033-...lld:pubmed
pubmed-article:9579033pubmed:year1998lld:pubmed
pubmed-article:9579033pubmed:articleTitlePreparation of alkyl-substituted indoles in the benzene portion. Part 15. Asymmetric synthesis of (+)-duocarmycin SA using novel procedure for preparation of hydroxyindoles.lld:pubmed
pubmed-article:9579033pubmed:affiliationResearch Foundation Itsuu Laboratory, Tokyo, Japan.lld:pubmed
pubmed-article:9579033pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:9579033pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed